-
1
-
-
33846449069
-
-
Becker G, Allgaier HP, Olschewski M, Olschewski M, Zahringer A, Blum HE, HECTOR Study Group et al (2007) Hector Study Group Long-acting octreotide versus placebo for treatment of advanced HCC: a randomized controlled double-blind study. Hepatology 45(1): 9-15
-
Becker G, Allgaier HP, Olschewski M, Olschewski M, Zahringer A, Blum HE, HECTOR Study Group et al (2007) Hector Study Group Long-acting octreotide versus placebo for treatment of advanced HCC: a randomized controlled double-blind study. Hepatology 45(1): 9-15
-
-
-
-
2
-
-
3442880408
-
Differential expression of somatostatin receptor subtypes in hepatocellular carcinomas
-
Blaker M, Schmitz M, Gocht A, Burghardt S, Schulz M, Broring DC, Pace A, Greten H, De Weerth A (2004) Differential expression of somatostatin receptor subtypes in hepatocellular carcinomas. J Hepatol 41(1): 112-118
-
(2004)
J Hepatol
, vol.41
, Issue.1
, pp. 112-118
-
-
Blaker, M.1
Schmitz, M.2
Gocht, A.3
Burghardt, S.4
Schulz, M.5
Broring, D.C.6
Pace, A.7
Greten, H.8
De Weerth, A.9
-
3
-
-
28844480321
-
Management of hepatocellular carcinoma
-
Bruix J, Sherman M (2005) Management of hepatocellular carcinoma. Hepatology 42(5): 1208-1236
-
(2005)
Hepatology
, vol.42
, Issue.5
, pp. 1208-1236
-
-
Bruix, J.1
Sherman, M.2
-
4
-
-
33749357994
-
-
Cebon J, Australasian Gastro-intestinal Trials group (AGITG) and Ag0001H Investigators (2006) Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide. Br J Cancer 95(7): 853-861
-
Cebon J, Australasian Gastro-intestinal Trials group (AGITG) and Ag0001H Investigators (2006) Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide. Br J Cancer 95(7): 853-861
-
-
-
-
5
-
-
0031977504
-
Treatment of hepatocellular carcinoma with octreotide: A randomised controlled study
-
Kouroumalis E, Skordilis P, Thermos K, Vasilaki A, Moschandrea J, Manousos ON (1998) Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study. Gut 42(3): 442-447
-
(1998)
Gut
, vol.42
, Issue.3
, pp. 442-447
-
-
Kouroumalis, E.1
Skordilis, P.2
Thermos, K.3
Vasilaki, A.4
Moschandrea, J.5
Manousos, O.N.6
-
6
-
-
3242732020
-
Expression of somatostatin receptors in normal and cirrhotic human liver and in hepatocellular carcinoma
-
Reynaert H, Rombouts K, Vandermonde A, Urbain D, Kumar U, Bioulac-Sage P, Pinzani M, Rosenbaum J, Geerts A (2004) Expression of somatostatin receptors in normal and cirrhotic human liver and in hepatocellular carcinoma. Gut 53(8): 1180- 1189
-
(2004)
Gut
, vol.53
, Issue.8
, pp. 1180-1189
-
-
Reynaert, H.1
Rombouts, K.2
Vandermonde, A.3
Urbain, D.4
Kumar, U.5
Bioulac-Sage, P.6
Pinzani, M.7
Rosenbaum, J.8
Geerts, A.9
-
7
-
-
15344344073
-
Octreotide therapy for advanced hepatocellular carcinoma
-
Slijkhuis WA, Stadheim L, Hassoun ZM, Nzeako UC, Kremers WK, Talwalkar JA, Gores GJ (2005) Octreotide therapy for advanced hepatocellular carcinoma. J Clin Gastroenterol 39(4): 333-338
-
(2005)
J Clin Gastroenterol
, vol.39
, Issue.4
, pp. 333-338
-
-
Slijkhuis, W.A.1
Stadheim, L.2
Hassoun, Z.M.3
Nzeako, U.C.4
Kremers, W.K.5
Talwalkar, J.A.6
Gores, G.J.7
-
8
-
-
33748351565
-
Impact of biomarkers on disease survival and progression in patients treated with octreotide for advanced hepatocellular carcinoma
-
Treiber G, Wex T, Rocken C, Fostitsch P, Malfertheiner P (2006) Impact of biomarkers on disease survival and progression in patients treated with octreotide for advanced hepatocellular carcinoma. J Cancer Res Clin Oncol 132(11): 699-708
-
(2006)
J Cancer Res Clin Oncol
, vol.132
, Issue.11
, pp. 699-708
-
-
Treiber, G.1
Wex, T.2
Rocken, C.3
Fostitsch, P.4
Malfertheiner, P.5
-
9
-
-
0036725135
-
A randomized placebo-controlled study of long-acting octreotide for treatment of advanced hepatocellular carcinoma
-
Yuen MF, Poon RT, Lai CL, Fan ST, Lo CM, Wong KW, Wong WM, Wong BC (2002) A randomized placebo-controlled study of long-acting octreotide for treatment of advanced hepatocellular carcinoma. Hepatology 36(3): 687-691
-
(2002)
Hepatology
, vol.36
, Issue.3
, pp. 687-691
-
-
Yuen, M.F.1
Poon, R.T.2
Lai, C.L.3
Fan, S.T.4
Lo, C.M.5
Wong, K.W.6
Wong, W.M.7
Wong, B.C.8
|